Prophylactic supplementation with Bifidobacterium infantis or its metabolite inosine attenuates cardiac ischemia/reperfusion injury

CAS OpenIR > 2024年度论文

	Prophylactic supplementation with Bifidobacterium infantis or its metabolite inosine attenuates cardiac ischemia/reperfusion injury
发表期刊	IMETA
	2024-08
卷号	3 期号:4
	Zhang, Hao; Wang, Jiawan; Shen, Jianghua; Chen, Siqi; Yuan, Hailong; Zhang, Xuan; Liu, Xu; Yu, Ying; Li, Xinran; Gao, Zeyu; Wang, Yaohui; Wang, Jun; Song, Moshi
关键词	INFLAMMATION HEART BIOMARKER ACID
文献类型	期刊论文
条目标识符	http://ir.ioz.ac.cn/handle/000000/16306
专题	2024年度论文
推荐引用方式 GB/T 7714	Zhang, Hao,Wang, Jiawan,Shen, Jianghua,et al. Prophylactic supplementation with Bifidobacterium infantis or its metabolite inosine attenuates cardiac ischemia/reperfusion injury[J]. IMETA,2024,3(4).
APA	Zhang, Hao.,Wang, Jiawan.,Shen, Jianghua.,Chen, Siqi.,Yuan, Hailong.,...&Song, Moshi.(2024).Prophylactic supplementation with Bifidobacterium infantis or its metabolite inosine attenuates cardiac ischemia/reperfusion injury.IMETA,3(4).
MLA	Zhang, Hao,et al."Prophylactic supplementation with Bifidobacterium infantis or its metabolite inosine attenuates cardiac ischemia/reperfusion injury".IMETA 3.4(2024).